Clinical Trial Update: Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing bicalutamide with observation followed by bicalutamide plus either goserelin or orchiectomy in prostate cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Goserelin (Goserelin)
• bicalutamide (bicalutamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED